Specific inhibition of cardiac and skeletal muscle sarcoplasmic reticulum Ca2+ pumps by H-89
- 1 November 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (9) , 991-998
- https://doi.org/10.1016/s0006-2952(97)00320-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The max of the Ca2+-ATPase of Cardiac Sarcoplasmic Reticulum (SERCA2a) Is Not Altered by Ca2+/Calmodulin-dependent Phosphorylation or by Interaction with PhospholambanPublished by Elsevier ,1996
- Purified, Reconstituted Cardiac Ca2+-ATPase Is Regulated by Phospholamban but Not by Direct Phosphorylation with Ca2+/Calmodulin-dependent Protein KinasePublished by Elsevier ,1996
- The Hydrophilic Domain of Phospholamban Inhibits the Ca2+-ATPase - The Importance of the Method of AssayBiochemical and Biophysical Research Communications, 1995
- Sarco(endo)plasmic Reticulum Calcium Pumps in the Cardiovascular System: Function and Gene ExpressionJournal of Molecular and Cellular Cardiology, 1994
- Protein Kinase Inhibitors: Probes for the Functions of Protein PhosphorylationPublished by Elsevier ,1991
- Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinaseBritish Journal of Pharmacology, 1989
- Proteolytic activation of the canine cardiac sarcoplasmic reticulum calcium pumpBiochemistry, 1986
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- Purification of morphologically intact triad structures from skeletal muscle.The Journal of cell biology, 1983
- Mechanism by which cyclic adenosine 3':5'-monophosphate-dependent protein kinase stimulates calcium transport in cardiac sarcoplasmic reticulum.Circulation Research, 1979